BIT
RIGL icon

BlackRock Institutional Trust’s Rigel Pharmaceuticals RIGL Stock Holding History

BlackRock Institutional Trust’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$8.07M Buy
339,172
+11,001
+3% +$315K ﹤0.01% 2524
2016
Q3 		$12M Buy
328,171
+3,285
+1% +$94.2K ﹤0.01% 2234
2016
Q2 		$7.25M Buy
324,886
+2,349
+0.7% +$58.4K ﹤0.01% 2487
2016
Q1 		$6.71M Sell
322,537
-10,442
-3% -$258K ﹤0.01% 2513
2015
Q4 		$10.1M Buy
332,979
+6,504
+2% +$197K ﹤0.01% 2317
2015
Q3 		$8.06M Sell
326,475
-15,977
-5% -$477K ﹤0.01% 2435
2015
Q2 		$11M Buy
342,452
+15,539
+5% +$594K ﹤0.01% 2348
2015
Q1 		$11.7M Buy
326,913
+371
+0.1% +$10.2K ﹤0.01% 2297
2014
Q4 		$7.41M Sell
326,542
-5,480
-2% -$111K ﹤0.01% 2533
2014
Q3 		$6.44M Buy
332,022
+677
+0.2% +$19.1K ﹤0.01% 2563
2014
Q2 		$12M Buy
331,345
+12,908
+4% +$439K ﹤0.01% 2317
2014
Q1 		$12.4M Buy
318,437
+14,644
+5% +$522K ﹤0.01% 2281
2013
Q4 		$8.66M Buy
303,793
+34,145
+13% +$1M ﹤0.01% 2498
2013
Q3 		$9.65M Sell
269,648
-22,563
-8% -$823K ﹤0.01% 2387
2013
Q2 		$9.76M Buy
+292,211
New +$13.2M ﹤0.01% 2330

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock Institutional Trust's RIGL Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Rigel Pharmaceuticals (RIGL) stake by 3.4% in Q4 2016, buying an estimated $315K and bringing the position to 339,172 shares worth $8.07M. The position accounts for ﹤0.01% of the portfolio, ranked #2524.

BlackRock Institutional Trust first reported a position in RIGL in Q2 2013 and has held it in 15 quarters since. The position peaked at $12.4M in Q1 2014. 107 funds tracked by Wall St. Rank hold RIGL as of Q4 2016.

  • BlackRock Institutional Trust held 339,172 shares of Rigel Pharmaceuticals worth $8.07M as of Q4 2016.
  • BlackRock Institutional Trust bought 11,001 Rigel Pharmaceuticals shares in Q4 2016, an estimated $315K.
  • Rigel Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2524 holding.
  • BlackRock Institutional Trust first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Rigel Pharmaceuticals position peaked at $12.4M in Q1 2014.
  • 107 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.